SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Samrat Pharmachem informs about board meeting

14 Apr 2017 Evaluate

Samrat Pharmachem has submitted a copy of notice of Board Meeting for Audited Financial Results for the Year ended March 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Samrat Pharmachem Share Price

240.00 -6.55 (-2.66%)
24-Jul-2026 10:05 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1950.20
Dr. Reddys Labs. 1139.50
Cipla 1418.60
Lupin 2350.50
Zydus Lifesciences 1109.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: